134 related articles for article (PubMed ID: 38549388)
1. Pulsed low-dose rate radiotherapy for recurrent bone sarcomas: case reports and brief review.
Wong RX; Master Z; Pang E; Yang V; Looi WS
Radiat Oncol J; 2024 Mar; 42(1):88-94. PubMed ID: 38549388
[TBL] [Abstract][Full Text] [Related]
2. Use of Pulsed Low-Dose Rate Radiotherapy in Refractory Malignancies.
Yan J; Yang J; Yang Y; Ren W; Liu J; Gao S; Li S; Kong W; Zhu L; Yang M; Qian X; Liu B
Transl Oncol; 2018 Feb; 11(1):175-181. PubMed ID: 29306203
[TBL] [Abstract][Full Text] [Related]
3. Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique.
Lee CT; Dong Y; Li T; Freedman S; Anaokar J; Galloway TJ; Hallman MA; Weiss SE; Hayes SB; Price RA; Ma CMC; Meyer JE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):959-964. PubMed ID: 29485075
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of PLDR-IMRT for the re-irradiation of recurrent NPC: A prospective, single-arm, multicenter trial.
Huang R; Li Z; Yang F; Zhang Y; Jiang Y; Li C; Gao H; Li G; Liu Y; Guo W; Yang D; Zhang S; Li J; Wen H; Lang J; Zhang P
Cancer Sci; 2023 Jun; 114(6):2534-2543. PubMed ID: 36788727
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
8. Local Tumor Control and Normal Tissue Toxicity of Pulsed Low-Dose Rate Radiotherapy for Recurrent Lung Cancer: An In Vivo Animal Study.
Zhang P; Wang B; Chen X; Cvetkovic D; Chen L; Lang J; Ma CM
Dose Response; 2015; 13(2):1559325815588507. PubMed ID: 26675811
[TBL] [Abstract][Full Text] [Related]
9. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center phase II trial.
Li J; Zhao Z; Du G; Dai T; Zhen X; Cai H; Liao D; Xiang M; Wen Y; Geng L; Yang X; Feng G; Zhang Y; Bai J; Liu L; Du X
Medicine (Baltimore); 2019 Jun; 98(26):e16176. PubMed ID: 31261551
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
[TBL] [Abstract][Full Text] [Related]
12. Reirradiation of recurrent breast cancer with and without concurrent chemotherapy.
Würschmidt F; Dahle J; Petersen C; Wenzel C; Kretschmer M; Bastian C
Radiat Oncol; 2008 Sep; 3():28. PubMed ID: 18801165
[TBL] [Abstract][Full Text] [Related]
13. Pulsed low dose-rate radiotherapy: radiobiology and dosimetry.
Ma CMC
Phys Med Biol; 2022 Jan; 67(3):. PubMed ID: 35038688
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome.
Ryg U; Seierstad T; Nilsen LB; Hellebust TP; Djupvik LH; Gustafson H; Hydal J; Kishan AU; Hole KH; Lilleby W
Front Oncol; 2022; 12():861127. PubMed ID: 35463376
[TBL] [Abstract][Full Text] [Related]
15. Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy.
Arpa D; Parisi E; Ghigi G; Savini A; Colangione SP; Tontini L; Pieri M; Foca F; Polico R; Tesei A; Sarnelli A; Romeo A
Sci Rep; 2020 Nov; 10(1):19321. PubMed ID: 33168845
[TBL] [Abstract][Full Text] [Related]
16. Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience.
Ren X; Fu Y; Liu Z; Lin X; Qiu L; Li Y; Li H; Bai Y; Wang T
Front Oncol; 2022; 12():943703. PubMed ID: 35928866
[TBL] [Abstract][Full Text] [Related]
17. Re‑irradiation plus hyperthermia for recurrent pediatric sarcoma; a simulation study to investigate feasibility.
Kok HP; Van Dijk IWEM; Crama KF; Franken NAP; Rasch CRN; Merks JHM; Crezee J; Balgobind BV; Bel A
Int J Oncol; 2019 Jan; 54(1):209-218. PubMed ID: 30387837
[TBL] [Abstract][Full Text] [Related]
18. Optimization strategies for pulsed low-dose-rate IMRT of recurrent lung and head and neck cancers.
Kang S; Lang J; Wang P; Li J; Lin M; Chen X; Guo M; Chen F; Chen L; Ma CM
J Appl Clin Med Phys; 2014 May; 15(3):4661. PubMed ID: 24892337
[TBL] [Abstract][Full Text] [Related]
19. Pulsed reduced dose-rate radiotherapy as re-irradiation for brain metastasis in a patient with lung squamous-celled carcinoma.
Li GH; Liu Y; Tang JL; Zhang D; Zhou P; Yang DQ; Ma CK
Jpn J Clin Oncol; 2012 Sep; 42(9):856-60. PubMed ID: 22701036
[TBL] [Abstract][Full Text] [Related]
20. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
